A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

TerminatedOBSERVATIONAL
Enrollment

4,121

Participants

Timeline

Start Date

December 2, 2013

Primary Completion Date

April 15, 2016

Study Completion Date

April 15, 2016

Conditions
Influenza Vaccine Effectiveness
Trial Locations (12)

27157

Research Site, Winston-Salem

32608

Research Site, Gainesville

37212

Research Site, Nashville

54449

Research Site, Marshfield

55440

Research Site, Bloomington

76508

Research Site, Temple

97227

Research Site, Portland

44308-1063

Research Site, Akron

BS2 8AE

Research Site, Bristol

OX3 7EJ

Research Site, Oxford

SO16 6YD

Research Site, Southampton

SW17 0QT

Research Site, Tooting

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

MedImmune LLC

INDUSTRY